BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10501502)

  • 1. Transcription-modulatory activities of differentially spliced cDNAs encoding the E2 protein of human papillomavirus type 16.
    Alloul N; Sherman L
    J Gen Virol; 1999 Sep; 80 ( Pt 9)():2461-2470. PubMed ID: 10501502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2 protein of human papillomavirus type 16 is translated from a variety of differentially spliced polycistronic mRNAs.
    Alloul N; Sherman L
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():29-37. PubMed ID: 9934680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer.
    Rotenberg MO; Chiang CM; Ho ML; Broker TR; Chow LT
    Virology; 1989 Oct; 172(2):468-77. PubMed ID: 2552658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
    Hubert WG; Laimins LA
    J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 protein.
    Sherman L; Alloul N
    Virology; 1992 Dec; 191(2):953-9. PubMed ID: 1333130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor.
    Chiang CM; Broker TR; Chow LT
    J Virol; 1991 Jun; 65(6):3317-29. PubMed ID: 1851879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
    Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
    J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs.
    Johnsen CK; Stanley M; Norrild B
    Intervirology; 1995; 38(6):339-45. PubMed ID: 8880384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53.
    Shally M; Alloul N; Jackman A; Muller M; Gissmann L; Sherman L
    Virus Res; 1996 Jun; 42(1-2):81-96. PubMed ID: 8806176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcriptional repressive activity of mutated E2 protein of human papillomavirus 2 (HPV-2) variant].
    Lei YJ; Gao C; Jiang HY; Han J; Chen JM; Shi Q; Zhou W; Yuan YK; Dong XP
    Bing Du Xue Bao; 2008 Jul; 24(4):268-71. PubMed ID: 18780628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein.
    Sethi N; Palefsky J
    Hum Gene Ther; 2003 Jan; 14(1):45-57. PubMed ID: 12573058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
    Kook JK; Kim JH; Min BM
    Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter activity of sequences located upstream of the human papillomavirus types of 16 and 18 late regions.
    Geisen C; Kahn T
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2193-200. PubMed ID: 8811019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16.
    Veress G; Szarka K; Dong XP; Gergely L; Pfister H
    J Gen Virol; 1999 Apr; 80 ( Pt 4)():1035-1043. PubMed ID: 10211974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.
    Phelps WC; Howley PM
    J Virol; 1987 May; 61(5):1630-8. PubMed ID: 3033289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16.
    Tan SH; Baker CC; Stünkel W; Bernard HU
    Virology; 2003 Jan; 305(2):486-501. PubMed ID: 12573593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter.
    Gao C; Pan MM; Lei YJ; Tian LQ; Jiang HY; Li XL; Shi Q; Tian C; Yuan YK; Fan GX; Dong XP
    BMC Mol Biol; 2012 Feb; 13():5. PubMed ID: 22333459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic activity of human papillomavirus type 16 E6/E7 cDNA clones isolated from SiHa cervical carcinoma cell line.
    Yamada T; Yamashita T; Nishikawa T; Fujimoto S; Fujinaga K
    Virus Genes; 1995; 10(1):15-25. PubMed ID: 7483285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16.
    Rohlfs M; Winkenbach S; Meyer S; Rupp T; Dürst M
    Virology; 1991 Jul; 183(1):331-42. PubMed ID: 1647072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bovine papillomavirus P2443 promoter is E2 trans-responsive: evidence for E2 autoregulation.
    Hermonat PL; Spalholz BA; Howley PM
    EMBO J; 1988 Sep; 7(9):2815-22. PubMed ID: 2846284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.